🔧 Recovery Blend
Wolverine Blend (BPC-157 / TB-500) Dosage Protocols: All Vial Sizes
Wolverine Blend combines BPC-157 and TB-500 in a single vial — the two most-studied tissue-repair peptides, working through complementary mechanisms. Choose your vial size below; each size has its own exact dosing table.
Choose Your Vial Size
| Vial | Final volume | Concentration | One U-100 unit | |
|---|---|---|---|---|
| 5 mg | 2 mL | 2.5 mg/mL | 25 mcg in 0.01 mL | Open protocol → |
| 10 mg | 3 mL | 3.33 mg/mL | 33.33 mcg total in 0.01 mL | Open protocol → |
| 20 mg | 3 mL | 6.67 mg/mL | 66.67 mcg total in 0.01 mL | Open protocol → |
Doses are the same research amounts across sizes; the vial size changes the concentration, so syringe units differ. Always use the table for your exact vial.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 28 days, protect from light |
Important Notes
⚠ Research Use Only: WADA prohibited (TB-500).
How This Works
BPC-157 provides local cytoprotection, angiogenesis, and tendon-cell migration. TB-500 provides systemic actin regulation and cell migration. The two work through complementary mechanisms; they are commonly combined in connective-tissue research protocols.
Potential Benefits & Side Effects
Potential Benefits
- Synergistic tissue-repair effects.
- Established research-grade combination.
- Suitable for both local and systemic protocols.
Side Effect Profile
- Combined profile of components.
- Injection-site reactions.
- Generally well-tolerated.
Lifestyle Factors
- Pair with appropriate physical therapy.
- Adequate protein and collagen-supportive nutrients.
- Avoid NSAIDs during early-phase repair.
Injection Technique
- Subcutaneous, abdomen/thigh/upper arm. Rotate sites if dosing twice daily.
References
1
See BPC-157 and TB-500 standalone references.